Live

The Marseille Cancer Research Center celebrates its 50th anniversary ! -

Nov 2018 British journal of cancer

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Authors

Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D

Summary

The immunologic constant of rejection (ICR) is a broad phenomenon of Th-1 immunity-mediated, tissue-specific destruction.

Read the article